GlassScriptPhysician profile
Nicole M Harrell
NPI 1972763340
$9,863.76
in general payments reported to CMS, 2019-2025
41 companies · $2,326 in 2025
The $2,326 reported for 2025 was more than what 79% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,117 · 2020: $513 · 2021: $970 · 2022: $1,693 · 2023: $1,520 · 2024: $1,724 · 2025: $2,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,470 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,470.38 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,139.65 | 2019-2025 | |
| Janssen Biotech, INC. | $1,042.74 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Amgen INC. | $1,009.05 | 2019-2025 | Otezla, Otezla |
| Genzyme Corporation | $983.57 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $862.68 | 2019-2025 | |
| Merz North America, INC. | $401.48 | 2019-2023 | Xeomin |
| E.R. Squibb & Sons, L.L.C. | $375.05 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $309.72 | 2019-2025 | Ilumya |
| Galderma Laboratories, L.P. | $302.66 | 2021-2025 | Nemluvio, Aklief, Epsolay |
| Ucb, INC. | $297.55 | 2020-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $257.88 | 2019-2025 | Dupixent |
| Pfizer INC. | $248.24 | 2022-2023 | |
| Leo Pharma INC. | $196.16 | 2021-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $131.00 | 2019-2023 | Taltz, Olumiant |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.64 | 2022-2025 | Spevigo |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $123.94 | 2020-2022 | |
| Celgene Corporation | $119.85 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $112.91 | 2019-2022 | |
| Medimetriks Pharmaceuticals, INC. | $110.63 | 2019-2020 | |
| Biofrontera INC. | $94.44 | 2019-2024 | Rhodoled Xl, Xepi, Bf-Rhodoled |
| Genentech USA, INC. | $76.12 | 2019-2022 | |
| Incyte Corporation | $67.70 | 2021-2025 | Opzelura |
| Botanix Sb INC | $60.28 | 2025 | Sofdra |
| Vyne Pharmaceuticals INC. | $55.34 | 2020-2021 | |
| Almirall LLC | $45.34 | 2019-2024 | Seysara |
| Dermavant Sciences, INC. | $44.75 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $43.86 | 2024 | Zoryve |
| Elekta, INC. | $33.79 | 2025 | Flexitron Hdr |
| Mayne Pharma Commercial LLC | $29.68 | 2019-2022 | |
| Mimedx Group, INC. | $29.02 | 2024 | |
| Kerecis Limited | $24.77 | 2022 | |
| Conmed Corporation | $20.25 | 2025 | Visiclear |
| Journey Medical Corporation | $18.12 | 2020 | |
| Dermira, INC. | $17.98 | 2019 | |
| Smith+Nephew, INC. | $17.63 | 2020 | |
| Convatec INC. | $16.49 | 2025 | |
| Cipher Pharmaceuticals US LLC | $15.80 | 2025 | Spinosad, Natroba |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Harrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.